Principal Financial Group Inc Nevro Corp Transaction History

Principal Financial Group Inc

$1.66 Trillion
Q3 2024

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$13.56 - $20.78 $119,775 - $183,549	-8,833 Reduced 1.23%	711,696 $10.3 Million
Q4 2023 Feb 07, 2024	BUY	$14.18 - $22.31 $43,759 - $68,848	3,086 Added 0.43%	720,529 $15.5 Million
Q3 2023 Nov 02, 2023	SELL	$18.22 - $25.85 $82,664 - $117,281	-4,537 Reduced 0.63%	717,443 $13.8 Million
Q2 2023 Aug 07, 2023	BUY	$22.62 - $39.32 $1.63 Million - $2.83 Million	72,024 Added 11.08%	721,980 $18.4 Million
Q1 2023 May 09, 2023	SELL	$30.17 - $41.11 $3.46 Million - $4.71 Million	-114,561 Reduced 14.98%	649,956 $23.5 Million
Q4 2022 Feb 09, 2023	SELL	$36.43 - $49.4 $1.05 Million - $1.42 Million	-28,823 Reduced 3.63%	764,517 $30.3 Million
Q3 2022 Nov 09, 2022	BUY	$40.66 - $53.03 $5.53 Million - $7.22 Million	136,107 Added 20.71%	793,340 $37 Million
Q2 2022 Aug 10, 2022	BUY	$40.85 - $77.67 $8.75 Million - $16.6 Million	214,157 Added 48.33%	657,233 $28.8 Million
Q1 2022 May 09, 2022	BUY	$59.95 - $92.06 $524,922 - $806,077	8,756 Added 2.02%	443,076 $32 Million
Q4 2021 Feb 09, 2022	BUY	$81.07 - $121.29 $15 Million - $22.5 Million	185,461 Added 74.52%	434,320 $35.2 Million
Q3 2021 Nov 09, 2021	SELL	$101.99 - $166.36 $2.2 Million - $3.59 Million	-21,563 Reduced 7.97%	248,859 $29 Million
Q2 2021 Aug 10, 2021	BUY	$141.6 - $179.06 $12.9 Million - $16.3 Million	90,894 Added 50.63%	270,422 $44.8 Million
Q1 2021 May 10, 2021	BUY	$132.81 - $182.18 $1.84 Million - $2.52 Million	13,832 Added 8.35%	179,528 $25 Million
Q4 2020 Feb 08, 2021	BUY	$138.17 - $184.34 $875,583 - $1.17 Million	6,337 Added 3.98%	165,696 $28.7 Million
Q3 2020 Nov 06, 2020	BUY	$114.09 - $145.51 $18,938 - $24,154	166 Added 0.1%	159,359 $22.2 Million
Q2 2020 Aug 05, 2020	BUY	$89.45 - $129.85 $3.34 Million - $4.84 Million	37,301 Added 30.6%	159,193 $19 Million
Q1 2020 May 12, 2020	SELL	$70.23 - $144.31 $1.41 Million - $2.89 Million	-20,032 Reduced 14.11%	121,892 $12.2 Million
Q4 2019 Feb 05, 2020	SELL	$76.41 - $117.54 $4.36 Million - $6.7 Million	-56,999 Reduced 28.65%	141,924 $16.7 Million
Q3 2019 Nov 13, 2019	SELL	$61.52 - $91.1 $7,690 - $11,387	-125 Reduced 0.06%	198,923 $17.1 Million
Q2 2019 Aug 12, 2019	SELL	$58.04 - $66.99 $357,816 - $412,993	-6,165 Reduced 3.0%	199,048 $12.9 Million
Q1 2019 May 10, 2019	BUY	$35.52 - $62.62 $1.26 Million - $2.23 Million	35,601 Added 20.99%	205,213 $12.8 Million
Q4 2018 Feb 14, 2019	SELL	$35.43 - $56.29 $846,139 - $1.34 Million	-23,882 Reduced 12.34%	169,612 $6.6 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $123,329 - $210,485	2,789 Added 1.46%	193,494 $11 Million
Q2 2018 Aug 13, 2018	SELL	$72.38 - $92.5 $872,830 - $1.12 Million	-12,059 Reduced 5.95%	190,705 $0
Q1 2018 May 14, 2018	SELL	$69.46 - $88.57 $63,833 - $81,395	-919 Reduced 0.45%	202,764 $17.6 Million
Q4 2017 Feb 13, 2018	SELL	$65.94 - $93.31 $4.73 Million - $6.69 Million	-71,700 Reduced 26.04%	203,683 $14.1 Million
Q3 2017 Nov 02, 2017	BUY	$80.87 - $91.08 $22.3 Million - $25.1 Million	275,383	275,383 $25 Million

Others Institutions Holding NVRO

# of Institutions

151

Shares Held

39.3M

Call Options Held

67.9K

Put Options Held

1.59M

Arrow Mark Colorado Holdings LLC Denver, CO

4.39M
Shares

$14.4 Million
0.35% of portfolio
Armistice Capital, LLC New York, NY

3.73M
Shares

$12.3 Million
0.35% of portfolio
Black Rock Inc. New York, NY

3.6M
Shares

$11.8 Million
0.0% of portfolio
Glenn Welling Engaged Capital LLC | Newport Beach, Ca

2.44M
Shares

$8.04 Million
2.49% of portfolio
Vanguard Group Inc Valley Forge, PA

2.1M
Shares

$6.9 Million
0.0% of portfolio

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $116M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account